Due to updated Australian standards, the existing label of our product “SpringLeaf Fat Clear Capsules” is no longer complying with the current Australian standards. Therefore we are initiating a recall of this product in the market, and we will then relaunch this same product soon with a new label that complies with the current requirements set by the Therapeutic Goods Administration (TGA).
We apologize for any inconvenience this may cause. You can return the product to the shop that you purchased from for a refund, or you can return the product to us for a refund.
What is the problem?
The product label is missing a required warning about phenylalanine. Spirulina, one of the product’s active ingredients, is naturally high in phenylalanine and its declaration is required under relevant labelling standards.
Additionally, the product specifies a maximum daily dose of 12 capsules, each containing 500 mg of poliglusam. This results in a total daily intake of 6000 mg, which significantly exceeds the permitted limit of 1750 mg as specified in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2025.
What are the risks?
Exposure to phenylalanine poses a serious risk to individuals with phenylketonuria (PKU), as it can lead to severe neurological complications if not carefully managed. Overconsumption of poliglusam may result in gastrointestinal discomfort and could interfere with the absorption of fat-soluble vitamins, particularly with prolonged use.
What should I do?
If you have a bottle of SpringLeaf Fat Clear from above batch numbers, do not use it. Call Homart Pharmaceutical’s customer service line to arrange the return of affected product and a refund.
If you have taken the medicine and are concerned that you may have been exposed to increased levels of poliglusam, you should seek medical advice from your medical practitioner.
Further information
Please contact Homart Pharmaceutical Pty Ltd customer service on +61 02 9648 2880 for further information.
Reporting problems
Consumers and health professionals are encouraged to report problems with medicines or vaccines. Your report will contribute to the TGA’s monitoring of these products.
The TGA cannot give advice about an individual's medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medicine or vaccine.
